Medicare billing address
CMS Medicare provider billing file
100 E Lancaster AveSuite 256 Med Bldg East
Wynnewood, PA 19096
CMS public data · NPI 1215936380
CMS public files list billing, prescribing, location, and participation fields for this NPI. Current plan networks, appointment availability, clinical outcomes, and patient-specific medical advice require separate verification.
CMS display name
Robert B Penne, MD
Specialty
Credential
MD
NPI
1215936380
Primary source state
PA
Data retrieval date
July 28, 2026
Where these numbers come from, and what they cannot tell you
Public CMS records, 2024 reporting year. These are historical Medicare fields, not proof of current coverage, appointment availability, quality, or what someone will pay.
This page shows Medicare billing and Part D prescribing data for Robert B Penne, MD from CMS public files. It covers 2024 claims data: services billed, the beneficiary panel, and the most-prescribed Part D drugs. It does not show current coverage, appointment availability, or quality ratings.
A licensed agent, not a call center
Peter Abilla, Licensed Medicare Insurance Sales Agent, NPN 22265186. Bring the doctors and prescriptions that matter to you, then check the details before you enroll.
Medicare participating
Yes
Individual assignment
Yes
Group assignment
Yes
CMS opt-out records
0
When CMS files list more than one address for the same NPI, each address stays tied to the CMS file that reported it.
CMS Medicare provider billing file
100 E Lancaster AveCMS Doctors & Clinicians file
100 E Lancaster AveCMS Doctors & Clinicians file
251 S Lincoln AveCMS Doctors & Clinicians file
775E Route 70In the 2024 CMS provider billing file, this NPI had 896 Medicare beneficiaries and 10,009 total services. The average beneficiary age was 76, and the average HCC risk score was 1.1.
Total Medicare allowed amount
$543,221.25
Total Medicare payment amount
$420,067.35
Medicare beneficiaries
896
Total services
10,009
These percentages describe the Medicare beneficiary panel in the CMS utilization file. They are not a diagnosis for any individual patient and are not a quality score.
Hyperlipidemia
75%
CMS beneficiary-panel share
Hypertension
70%
CMS beneficiary-panel share
Ischemic heart disease
28%
CMS beneficiary-panel share
Diabetes
24%
CMS beneficiary-panel share
Osteoporosis
24%
CMS beneficiary-panel share
Anxiety
24%
CMS beneficiary-panel share
Where these service numbers come from, and what they cannot tell you
Amounts shown are average Medicare-approved amounts per billed unit in CMS records. What a person pays depends on current coverage and cannot be read from this table alone.
| CMS service description | Services | Avg allowed |
|---|---|---|
| Injection, onabotulinumtoxina, 1 unit | 6,050 | $6.15 |
| Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more | 512 | $97.41 |
| New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more | 386 | $181.11 |
| Photography of content of eyes | 363 | $25.62 |
| Established patient problem focused exam of visual system | 144 | $95.59 |
| Insertion of probe into nasal tear duct | 137 | $203.53 |
| Established patient complete exam of visual system | 97 | $134.92 |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | 93 | $139.20 |
| Repair of tendon of upper eyelid | 90 | $925.17 |
| Injection of chemical for paralysis of nerve muscles on side of face | 71 | $158.93 |
Where these Part D numbers come from, and what they cannot tell you
CMS data reports historical prescription drug events attributed to NPI 1215936380. Formularies, copays, prior authorization, and step therapy rules vary by current coverage.
| Rank | Drug | Generic name | Total claims | 30-day fills | Total drug cost |
|---|---|---|---|---|---|
| 1 | Erythromycin | Erythromycin Base | 363 | 367.2 | $3,800.15 |
| 2 | Neomycin-Polymyxin-Dexameth | Neomycin/Polymyxin B/Dexametha | 332 | 350.2 | $3,534.59 |
| 3 | Restasis | Cyclosporine | 42 | 58 | $33,983.86 |
| 4 | Latanoprost | Latanoprost | 40 | 80.5 | $325.37 |
| 5 | Cyclosporine | Cyclosporine | 19 | 31 | $7,537.80 |
| 6 | Xiidra | Lifitegrast | 17 | 35 | $23,316.18 |
| 7 | Prednisolone Acetate | Prednisolone Acetate | 16 | 25.4 | $388.77 |
| 8 | Travoprost | Travoprost | 14 | 25.3 | $1,308.63 |
| 9 | Doxycycline Hyclate | Doxycycline Hyclate | 13 | 13.2 | $192.27 |
| 10 | Tobramycin-Dexamethasone | Tobramycin/Dexamethasone | 12 | 12.2 | $498.92 |
CMS Part D records are historical aggregate claims data. They do not include current formulary status, pharmacy price, prior-authorization rules, network-directory status, or clinical-outcome data.
Medical school
University Of Minnesota Medical School
Graduation year
1984
Group/practice field
Annesley Flanagan Fischer Stefanyszyn And Associates
Telehealth reported
Not reported
Secondary specialty fields reported by CMS: Plastic And Reconstructive Surgery.
Verify plan-directory status, drug formulary rules, pharmacy pricing, appointment availability, and clinical questions against current plan documents and the relevant provider or care team.
The numbers above come from CMS public-use files for this NPI. Each link identifies the CMS release used and the retrieval date.